Senestech, Inc. (NASDAQ:SNES – Get Free Report) major shareholder Glenbrook Capital Management acquired 34,613 shares of the firm’s stock in a transaction on Thursday, February 19th. The shares were bought at an average cost of $2.40 per share, for a total transaction of $83,071.20. Following the acquisition, the insider owned 704,211 shares in the company, valued at approximately $1,690,106.40. The trade was a 5.17% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Large shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.
Glenbrook Capital Management also recently made the following trade(s):
- On Wednesday, February 18th, Glenbrook Capital Management bought 10,481 shares of Senestech stock. The stock was bought at an average cost of $2.29 per share, with a total value of $24,001.49.
- On Tuesday, February 17th, Glenbrook Capital Management bought 40,807 shares of Senestech stock. The shares were bought at an average price of $2.29 per share, for a total transaction of $93,448.03.
- On Friday, February 13th, Glenbrook Capital Management purchased 15,390 shares of Senestech stock. The shares were bought at an average cost of $1.89 per share, for a total transaction of $29,087.10.
- On Thursday, February 12th, Glenbrook Capital Management acquired 7,956 shares of Senestech stock. The stock was bought at an average price of $1.72 per share, with a total value of $13,684.32.
- On Wednesday, February 11th, Glenbrook Capital Management acquired 8,000 shares of Senestech stock. The shares were purchased at an average cost of $1.73 per share, for a total transaction of $13,840.00.
- On Thursday, February 5th, Glenbrook Capital Management acquired 2,884 shares of Senestech stock. The shares were purchased at an average cost of $1.77 per share, for a total transaction of $5,104.68.
- On Wednesday, February 4th, Glenbrook Capital Management acquired 5,685 shares of Senestech stock. The stock was purchased at an average price of $1.82 per share, for a total transaction of $10,346.70.
- On Monday, February 2nd, Glenbrook Capital Management bought 42,739 shares of Senestech stock. The shares were purchased at an average price of $1.98 per share, with a total value of $84,623.22.
- On Friday, January 30th, Glenbrook Capital Management purchased 5,399 shares of Senestech stock. The shares were purchased at an average cost of $1.87 per share, for a total transaction of $10,096.13.
Senestech Trading Up 2.6%
Senestech stock traded up $0.06 during mid-day trading on Thursday, hitting $2.40. The stock had a trading volume of 126,958 shares, compared to its average volume of 69,302. The stock has a 50-day simple moving average of $2.13 and a two-hundred day simple moving average of $3.34. The company has a current ratio of 15.75, a quick ratio of 14.73 and a debt-to-equity ratio of 0.01. The stock has a market capitalization of $12.53 million, a PE ratio of -0.66 and a beta of 0.21. Senestech, Inc. has a 12 month low of $1.30 and a 12 month high of $6.24.
Hedge Funds Weigh In On Senestech
Analyst Ratings Changes
Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Senestech in a research note on Monday, December 29th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold”.
Check Out Our Latest Stock Analysis on Senestech
About Senestech
SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.
The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.
Featured Articles
- Five stocks we like better than Senestech
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- Elon Musk: This Could Turn $100 into $100,000
Receive News & Ratings for Senestech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech and related companies with MarketBeat.com's FREE daily email newsletter.
